Completed OBSERVATIONAL NCT01363271

Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients

Sponsor: Lodise & Lodise, LLC

Conditions Complicated Skin and Structure Infection Nosocomial Pneumonia

Updated 9 times since 2017 Last updated: May 21, 2012 Started: May 31, 2011 Primary completion: May 31, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01363271, this observational or N/A phase trial focuses on Complicated Skin and Structure Infection and Nosocomial Pneumonia and remains completed. Sponsored by Lodise & Lodise, LLC, it has been updated 9 times since 2011, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2022 — Jul 2024 [monthly]

Completed
Jan 2021 — Mar 2022 [monthly]

Completed
Sep 2019 — Jan 2021 [monthly]

Completed

▶ Show 4 earlier versions

Jun 2018 — Sep 2019 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: PHASE4 → None
Feb 2017 — Apr 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

May 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lodise & Lodise, LLC
Pfizer
University of Maryland

Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.